RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.
We have previously demonstrated that loss of the tumor suppressive activity of ribosomal protein (RP) RPL22 predisposes to development of leukemia in mouse models and aggressive disease in human patients; however, the role of RPL22 in solid tumors, specifically colorectal cancer (CRC), had not been...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0222392 |
| _version_ | 1830441583256797184 |
|---|---|
| author | Shuyun Rao Suraj Peri Jens Hoffmann Kathy Q Cai Bryan Harris Michele Rhodes Denise C Connolly Joseph R Testa David L Wiest |
| author_facet | Shuyun Rao Suraj Peri Jens Hoffmann Kathy Q Cai Bryan Harris Michele Rhodes Denise C Connolly Joseph R Testa David L Wiest |
| author_sort | Shuyun Rao |
| collection | DOAJ |
| description | We have previously demonstrated that loss of the tumor suppressive activity of ribosomal protein (RP) RPL22 predisposes to development of leukemia in mouse models and aggressive disease in human patients; however, the role of RPL22 in solid tumors, specifically colorectal cancer (CRC), had not been explored. We report here that RPL22 is either deleted or mutated in 36% of CRC and provide new insights into its mechanism of action. Indeed, Rpl22 inactivation causes the induction of its highly homologous paralog, RPL22L1, which serves as a driver of cell proliferation and anchorage-independent growth in CRC cells. Moreover, RPL22L1 protein is highly expressed in patient CRC samples and correlates with poor survival. Interestingly, the association of high RPL22L1 expression with poor prognosis appears to be linked to resistance to 5-Fluorouracil, which is a core component of most CRC therapeutic regimens. Indeed, in an avatar trial, we found that human CRC samples that were unresponsive to 5-Fluorouracil in patient-derived xenografts exhibited elevated expression levels of RPL22L1. This link between RPL22L1 induction and 5-Fluorouracil resistance appears to be causal, because ectopic expression or knockdown of RPL22L1 in cell lines increases and decreases 5-Fluorouracil resistance, respectively, and this is associated with changes in expression of the DNA-repair genes, MGMT and MLH1. In summary, our data suggest that RPL22L1 might be a prognostic marker in CRC and predict 5-FU responsiveness. |
| first_indexed | 2024-12-21T05:25:15Z |
| format | Article |
| id | doaj.art-a159016e8ae7439f943b54efe9cd555c |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T05:25:15Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-a159016e8ae7439f943b54efe9cd555c2022-12-21T19:14:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022239210.1371/journal.pone.0222392RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.Shuyun RaoSuraj PeriJens HoffmannKathy Q CaiBryan HarrisMichele RhodesDenise C ConnollyJoseph R TestaDavid L WiestWe have previously demonstrated that loss of the tumor suppressive activity of ribosomal protein (RP) RPL22 predisposes to development of leukemia in mouse models and aggressive disease in human patients; however, the role of RPL22 in solid tumors, specifically colorectal cancer (CRC), had not been explored. We report here that RPL22 is either deleted or mutated in 36% of CRC and provide new insights into its mechanism of action. Indeed, Rpl22 inactivation causes the induction of its highly homologous paralog, RPL22L1, which serves as a driver of cell proliferation and anchorage-independent growth in CRC cells. Moreover, RPL22L1 protein is highly expressed in patient CRC samples and correlates with poor survival. Interestingly, the association of high RPL22L1 expression with poor prognosis appears to be linked to resistance to 5-Fluorouracil, which is a core component of most CRC therapeutic regimens. Indeed, in an avatar trial, we found that human CRC samples that were unresponsive to 5-Fluorouracil in patient-derived xenografts exhibited elevated expression levels of RPL22L1. This link between RPL22L1 induction and 5-Fluorouracil resistance appears to be causal, because ectopic expression or knockdown of RPL22L1 in cell lines increases and decreases 5-Fluorouracil resistance, respectively, and this is associated with changes in expression of the DNA-repair genes, MGMT and MLH1. In summary, our data suggest that RPL22L1 might be a prognostic marker in CRC and predict 5-FU responsiveness.https://doi.org/10.1371/journal.pone.0222392 |
| spellingShingle | Shuyun Rao Suraj Peri Jens Hoffmann Kathy Q Cai Bryan Harris Michele Rhodes Denise C Connolly Joseph R Testa David L Wiest RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. PLoS ONE |
| title | RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. |
| title_full | RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. |
| title_fullStr | RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. |
| title_full_unstemmed | RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. |
| title_short | RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. |
| title_sort | rpl22l1 induction in colorectal cancer is associated with poor prognosis and 5 fu resistance |
| url | https://doi.org/10.1371/journal.pone.0222392 |
| work_keys_str_mv | AT shuyunrao rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT surajperi rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT jenshoffmann rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT kathyqcai rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT bryanharris rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT michelerhodes rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT denisecconnolly rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT josephrtesta rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance AT davidlwiest rpl22l1inductionincolorectalcancerisassociatedwithpoorprognosisand5furesistance |